Skip to main content

Table 3 Mean (SD) of each group, mean (SD) difference within each group, and mean (95% CI) difference between groups

From: Intensive therapy after botulinum toxin in adults with spasticity after stroke versus botulinum toxin alone or therapy alone: a pilot, feasibility randomized trial

Outcome

Groups

Difference within groups

Difference between groups

 

Week 0

Week 8

Week 12

Week 8 minus week 0

Week 12 minus week 0

Week 8 minus week 0

Week 12 minus week 0

 

Exp

Con 1

Con 2

Exp

Con 1

Con 2

Exp

Con 1

Con 2

Exp

Con 1

Con 2

Exp

Con 1

Con 2

Exp minus Con 1

Exp minus Con 2

Exp minus Con 1

Exp minus Con 2

Goal Attainment Scale (T-score)

23 (0)

n = 12

23 (0) n = 11

23 (0)

n = 14

40 (14)

n = 12

31 (9)

n = 9

38 (9)

n = 12

40 (13)

n = 12

36 (13)

n = 8

36 (9)

n = 12

17 (14)

8 (9)

15 (9)

17 (13)

13 (13)

13 (9)

9 (− 20 to 2)

2 (− 9 to 13)

4 (− 9 to 17)

4 (− 7 to 16)

Box and Block Test(blocks/s)

0.14 (0.21)

n = 9

0.00 (0.00)

n = 6

0.05 (0.10)

n = 11

0.13 (0.18)

n = 9

0.01 (0.01)

n = 5

0.07 (0.16)

n = 11

0.12 (0.19)

n = 9

0.02 (0.04)

n = 5

0.07 (0.15)

n = 11

− 0.01 (0.05)

0.01 (0.01)

0.02 (0.07)

− 0.02 (0.06)

0.02 (0.04)

0.02 (0.07)

− 0.02 (− 0.06 to 0.03)

− 0.03 (− 0.09 to 0.03)

− 0.04 (− 0.10 to 0.03)

− 0.04 (− 0.10 to 0.02)

6-min Walk Test(m/s)

0.18 (0.16)

n = 3

0.54 (0.05)

n = 5

0.46 (0.58)

n = 3

0.28 (0.24)

n = 3

0.61 (0.17)

n = 4

0.46 (0.53)

n = 3

0.27 (0.23)

n = 3

0.62 (0.29)

n = 4

0.35 (0.60)

n = 3

0.10 (0.09)

0.07 (0.19)

0.01 (0.09)

0.09 (0.09)

0.08 (0.30)

− 0.11 (0.13)

0.02 (− 0.29 to 0.33)

0.09 (− 0.12 to 0.29)

0.01 (− 0.46 to 0.48)

0.20 (− 0.05 to 0.44)

Tardieu Scale(0–4)

2.5 (0.7)

n = 12

2.2 (0.4)

n = 11

2.2 (0.6)

n = 14

2.5 (0.7)

n = 11

2.3 (0.5)

n = 9

2.0 (0.5)

n = 13

2.3 (0.7)

n = 12

2.2 (0.4)

n = 9

2.2 (0.8)

n = 12

− 0.1 (0.3)

− 0.2 (0.8)

0.1 (0.3)

− 0.2 (0.4)

0.0 (1.1)

0.0 (0.0)

0.1 (− 0.4 to 0.7)

− 0.2(− 0.4 to 0.1)

− 0.2 (− 0.9 to 0.6)

−20090.2 (− 0.4 to 0.1)

  1. Exp experimental group (botulinum toxin-A plus intensive therapy), Con 1 control group 1 (botulinum toxin-A only), Con 2 control group 2 (intensive therapy only)